DisclosureDisclosure

Disclosure

45. To improve the understanding of its capital adequacy position by policy owners and other market participants, a life company must publish, at least annually, the following items for the life company as a whole:
(a) the amount of Common Equity Tier 1 Capital;
(b) the aggregate amount of any regulatory adjustments applied in the calculation of Common Equity Tier 1 Capital;
(c) the amount of Additional Tier 1 Capital;
(d) the aggregate amount of any regulatory adjustments applied in the calculation of Additional Tier 1 Capital;
(e) the amount of Tier 2 Capital;
(f) the aggregate amount of any regulatory adjustments applied in the calculation of Tier 2 Capital;
(g) the total capital base of the life company derived from the items (a) to (f);
(h) the prescribed capital amount; and
(i) the capital adequacy multiple (item (g) divided by item (h)).
46. A life company must also publish, at least annually, the following items for each of its funds:
(a) the amount of the fund’s ‘net assets’, after applying any regulatory adjustments;
(b) the aggregate amount of any regulatory adjustments applied to the fund’s net assets;
(c) the amount of Tier 2 Capital held by the fund;
(d) the aggregate amount of any regulatory adjustments applied in the calculation of the fund’s Tier 2 Capital;
(e) the total capital base of the fund derived from the items (a) to (d);
(f) the fund’s prescribed capital amount;
(g) the components of the fund’s prescribed capital amount[\[3\]](#_ftn3) specified in paragraph 29[\[4\]](#_ftn4); and
(h) the capital adequacy multiple of the fund (item (e) divided by item (f)).
47. A life company must publish the information specified in paragraphs 45 and 46 so that it is readily accessible to both policy owners and other market participants.
48. A life company must not disclose any supervisory adjustment determined by APRA in accordance with paragraph 44.